Dachun Xu

2.0k total citations
50 papers, 1.4k citations indexed

About

Dachun Xu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dachun Xu has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 14 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dachun Xu's work include Cardiovascular Function and Risk Factors (9 papers), Heart Failure Treatment and Management (8 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Dachun Xu is often cited by papers focused on Cardiovascular Function and Risk Factors (9 papers), Heart Failure Treatment and Management (8 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Dachun Xu collaborates with scholars based in China, United States and Hong Kong. Dachun Xu's co-authors include Yawei Xu, Dayi Hu, Yunsheng Ma, Jue Li, Liling Zou, Yifan Zhao, Xinyu Weng, Sherry Pagoto, Haipeng Guo and Ximin Fan and has published in prestigious journals such as Circulation, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Dachun Xu

48 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dachun Xu China 19 496 459 389 290 206 50 1.4k
Evren Caglayan Germany 24 507 1.0× 502 1.1× 334 0.9× 285 1.0× 120 0.6× 62 1.7k
Ting‐Hsing Chao Taiwan 19 566 1.1× 259 0.6× 395 1.0× 118 0.4× 87 0.4× 84 1.3k
Zhinong Wang China 22 586 1.2× 423 0.9× 439 1.1× 135 0.5× 211 1.0× 87 1.6k
Vaiva Lesauskaitė Lithuania 18 230 0.5× 246 0.5× 193 0.5× 260 0.9× 166 0.8× 91 1.0k
Włodzimierz J. Musiał Poland 22 877 1.8× 420 0.9× 434 1.1× 264 0.9× 93 0.5× 146 2.0k
Yoshiro Naito Japan 23 562 1.1× 369 0.8× 395 1.0× 447 1.5× 127 0.6× 115 1.8k
Kou‐Gi Shyu Taiwan 30 904 1.8× 850 1.9× 517 1.3× 183 0.6× 318 1.5× 65 2.3k
Xiaolei Yang China 19 482 1.0× 396 0.9× 123 0.3× 140 0.5× 116 0.6× 98 1.2k
Nobuhiko Ogata Japan 16 408 0.8× 151 0.3× 358 0.9× 233 0.8× 90 0.4× 50 962
Paul C. Armstrong United Kingdom 23 543 1.1× 234 0.5× 219 0.6× 149 0.5× 88 0.4× 50 1.4k

Countries citing papers authored by Dachun Xu

Since Specialization
Citations

This map shows the geographic impact of Dachun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dachun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dachun Xu more than expected).

Fields of papers citing papers by Dachun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dachun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dachun Xu. The network helps show where Dachun Xu may publish in the future.

Co-authorship network of co-authors of Dachun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Dachun Xu. A scholar is included among the top collaborators of Dachun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dachun Xu. Dachun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Yanhua, Wenqing Zhu, Yang Su, et al.. (2024). Characterization of a novel mitophagy-related 5-genes signature for diagnosis of acute myocardial infarction. Vascular Pharmacology. 156. 107417–107417. 1 indexed citations
3.
Xu, Dachun, et al.. (2023). Epigenetic Regulation of Fibroblasts and Crosstalk between Cardiomyocytes and Non-Myocyte Cells in Cardiac Fibrosis. Biomolecules. 13(9). 1382–1382. 10 indexed citations
4.
Li, Yuhao, Hui Zhao, Xing Chang, et al.. (2023). Large animal models of cardiac ischemia-reperfusion injury: Where are we now?. 动物学研究. 44(3). 591–603. 12 indexed citations
5.
Xu, Yanhua, Yifan Liu, Zeyu Wang, et al.. (2023). Plasma GAS6 predicts mortality risk in acute heart failure patients: insights from the DRAGON-HF trial. Journal of Translational Medicine. 21(1). 21–21. 6 indexed citations
6.
Chang, Xing, Nur Izzah Ismail, Dachun Xu, et al.. (2022). Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?. Antioxidants and Redox Signaling. 38(7-9). 599–618. 37 indexed citations
7.
Liu, Yifan, Yawei Xu, Chen Chi, et al.. (2022). Prognostic Value of Plasma sAXL in Patients with Heart Failure: Insights from the DRAGON-HF Trial. ESC Heart Failure. 10(1). 661–672. 2 indexed citations
8.
Yao, Su, et al.. (2022). PLK inhibitors identified by high content phenotypic screening promote maturation of human PSC-derived cardiomyocytes. Biochemical and Biophysical Research Communications. 620. 113–120. 4 indexed citations
9.
Cheang, Iokfai, Shi Shi, Xinyi Lu, et al.. (2022). Efficacy and Dosage Pattern of Sacubitril/Valsartan in Chinese Heart Failure with Reduced Ejection Fraction Patients. Journal of Cardiovascular Translational Research. 15(5). 1192–1202. 4 indexed citations
10.
Xu, Yanhua, Yang Su, Sang‐Bing Ong, et al.. (2021). Single-Cell Transcriptome Analysis Decipher New Potential Regulation Mechanism of ACE2 and NPs Signaling Among Heart Failure Patients Infected With SARS-CoV-2. Frontiers in Cardiovascular Medicine. 8. 628885–628885. 18 indexed citations
11.
Wang, Wei, Yang Su, Yuxi Sun, et al.. (2020). Optimal duration of Vitamin K antagonists anticoagulant therapy after venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders. 20(1). 53–53. 1 indexed citations
12.
Su, Yang, Zeyu Wang, Bin Dong, et al.. (2020). Efficacy of Early Initiation of Ivabradine Treatment in Patients with Acute Heart Failure: Rationale and Design of SHIFT-AHF Trial. ESC Heart Failure. 7(6). 4465–4471. 7 indexed citations
13.
Wang, Dongzhi, Hailing Li, Ε. Kenneth Weir, et al.. (2019). Dimethylarginine dimethylaminohydrolase 1 deficiency aggravates monocrotaline-induced pulmonary oxidative stress, pulmonary arterial hypertension and right heart failure in rats. International Journal of Cardiology. 295. 14–20. 16 indexed citations
14.
Xu, Dachun, Yifan Zhao, Xinyu Weng, et al.. (2019). Novel role of mitochondrial GTPases 1 in pathological cardiac hypertrophy. Journal of Molecular and Cellular Cardiology. 128. 105–116. 11 indexed citations
15.
Liu, Xiaoyu, Lei Hou, Dachun Xu, et al.. (2016). Effect of asymmetric dimethylarginine (ADMA) on heart failure development. Nitric Oxide. 54. 73–81. 43 indexed citations
16.
Xu, Dachun, et al.. (2015). Characterization of porcine GAS6 cDNA gene and its expression analysis in weaned piglets. Genetics and Molecular Research. 14(4). 17660–17672. 1 indexed citations
17.
Dai, Neng, Dachun Xu, Lei Hou, et al.. (2014). A Comparison of 2 Devices for Radial Artery Hemostasis After Transradial Coronary Intervention. The Journal of Cardiovascular Nursing. 30(3). 192–196. 27 indexed citations
18.
Dai, Neng, Dachun Xu, Ji Zhang, et al.. (2013). Different β-Blockers and Initiation Time in Patients Undergoing Noncardiac Surgery: A Meta-analysis. The American Journal of the Medical Sciences. 347(3). 235–244. 10 indexed citations
19.
Dai, Neng, Yi Zhang, Dachun Xu, et al.. (2013). Diagnostic performance of noninvasive cardiac imaging modalities to detect obstructive coronary artery disease. International Journal of Cardiology. 168(5). 5057–5059. 2 indexed citations
20.
Chen, Rongsheng, et al.. (1999). Anatomic basis of iliac crest flap pedicled on the iliolumbar artery. Surgical and Radiologic Anatomy. 21(2). 103–107. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evren Caglayan Breakdown of academic impact, for papers by Ting‐Hsing Chao Breakdown of academic impact, for papers by Zhinong Wang Breakdown of academic impact, for papers by Vaiva Lesauskaitė Breakdown of academic impact, for papers by Włodzimierz J. Musiał Breakdown of academic impact, for papers by Yoshiro Naito Breakdown of academic impact, for papers by Kou‐Gi Shyu Breakdown of academic impact, for papers by Xiaolei Yang Breakdown of academic impact, for papers by Nobuhiko Ogata Breakdown of academic impact, for papers by Paul C. Armstrong
Rankless by CCL
2026